Andrew Lawrence

Andrew Lawrence is a Lecturer in Biomedical Sciences at the University of Southampton. He previously held a Lecturer position in Molecular Biosciences at the University of Kent from 2019, after completing a postdoctoral role there (2007–2018). His affiliations include membership in the Molecular and Precision Biosciences research group and the ChemLife Network. He specializes in enzymology and biosynthetic pathways, particularly vitamin B12 metabolism and natural product synthesis.

Andrew obtained a BSc in Biochemistry and Chemistry (double Hons) from the University of Southampton in 2003 and a PhD in Molecular Biosciences at Queen Mary University of London (2003–2007). His research integrates biochemical and chemical approaches to study redox-active proteins, tetrapyrrole biosynthesis, and corrinoid cofactors. He develops fluorescent analogs and synthetic ligands to track vitamin B12 uptake and distribution in organisms like bacteria, algae, and malaria parasites.

His publications focus on cobalamin analogues (e.g., nickel and zinc substitutes), metabolic pathway elucidation, and protein function. This cross-disciplinary work bridges organic chemistry and microbiology, with applications in understanding cellular metal dynamics and metabolic deficiencies.

• Grants: Received funding from the Biotechnology & Biological Sciences Research Council (BBSRC).

Andrew advises PhD students (accepting applications) and collaborates on research projects spanning Southampton and Kent. His involvement in the ChemLife Network highlights his role in interdisciplinary chemical-biological research. No scientific awards are listed in the provided texts.

Active in molecular biosciences and biomedical research groups, his work contributes to understanding vitamin B12’s role in health and developing novel experimental tools for metabolic studies.